Yüklüyor......
Parathyroid Apoplexy Following Cinacalcet Treatment in Primary Hyperparathyroidism
Cinacalcet, a calcimimetic drug, is considered a safe and valid option for the treatment of hypercalcemia in patients with primary hyperparathyroidism who are unable to undergo parathyroidectomy. Hypocalcemia and gastrointestinal adverse reactions are the main side effects reported in patients treat...
Kaydedildi:
| Yayımlandı: | Front Endocrinol (Lausanne) |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6308315/ https://ncbi.nlm.nih.gov/pubmed/30622514 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2018.00777 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|